Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle

(2018) Prabir Roy-Chaudhury et al.   KIDNEY INTERNATIONAL

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients

(2017) Thomas A. Mavrakanas et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF

(2016) Kevin E. Chan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine

(2016) John H. Alexander et al.   JAMA Cardiology

Risk of Stroke in Patients with ESRD

(2015) P. Masson et al.   Clinical Journal of the American Society of Nephrology

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis

(2015) Xiaoli Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Changes in Renal Function in Patients With Atrial Fibrillation

(2015) Michael Böhm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

(2014) Craig T. January et al.   CIRCULATION

Risk of Stroke in Long-term Dialysis Patients Compared With the General Population

(2013) Hsi-Hao Wang et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Statin Use and Calcific Uremic Arteriolopathy: A Matched Case-Control Study

(2013) Sagar U. Nigwekar et al.   AMERICAN JOURNAL OF NEPHROLOGY

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

(2013) T. van der Hulle et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)

(2010) Elsayed Z. Soliman et al.   AMERICAN HEART JOURNAL

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

(2010) Renato D. Lopes et al.   AMERICAN HEART JOURNAL

Warfarin in haemodialysis patients with atrial fibrillation: what benefit?

(2010) F. Yang et al.   EUROPACE

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

(2010)   LANCET

Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study

(2009) Hiroshi Watanabe et al.   AMERICAN HEART JOURNAL

Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease

(2009) W. Ananthapanyasut et al.   Clinical Journal of the American Society of Nephrology

Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients

(2009) K. E. Chan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE